GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Market Cap

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Market Cap : د.إ1,088 Mil (As of Apr. 29, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gulf Pharmaceutical Industries PSC's share price for the quarter that ended in Dec. 2023 was د.إ0.769. Gulf Pharmaceutical Industries PSC's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,155 Mil. Therefore, Gulf Pharmaceutical Industries PSC's market cap for the quarter that ended in Dec. 2023 was د.إ888 Mil.

Gulf Pharmaceutical Industries PSC's quarterly market cap declined from Jun. 2023 (د.إ987 Mil) to Sep. 2023 (د.إ965 Mil) and declined from Sep. 2023 (د.إ965 Mil) to Dec. 2023 (د.إ888 Mil).

Gulf Pharmaceutical Industries PSC's annual market cap declined from Dec. 2021 (د.إ2,126 Mil) to Dec. 2022 (د.إ1,340 Mil) and declined from Dec. 2022 (د.إ1,340 Mil) to Dec. 2023 (د.إ888 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gulf Pharmaceutical Industries PSC's Enterprise Value for Today is د.إ1,938 Mil.


Gulf Pharmaceutical Industries PSC Market Cap Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Market Cap Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,130.45 1,536.46 2,125.62 1,340.07 888.37

Gulf Pharmaceutical Industries PSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,340.07 1,051.26 986.57 964.62 888.37

Competitive Comparison of Gulf Pharmaceutical Industries PSC's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gulf Pharmaceutical Industries PSC's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Market Cap distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Market Cap falls into.



Gulf Pharmaceutical Industries PSC Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Gulf Pharmaceutical Industries PSC's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=د.إ0.769*1155.23
=د.إ888

Gulf Pharmaceutical Industries PSC's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=د.إ0.769*1155.23
=د.إ888

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Gulf Pharmaceutical Industries PSC Market Cap Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Traded in Other Exchanges
N/A
Address
Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines